Fundz

Harmony Biosciences Appoints Peter Anastasiou as Chief Executive Officer

PUBLIC · HRMYOct 12, 2026
Internal move“Peter Anastasiou has served as Sr. EVP and chief operating officer at Harmony Biosciences and previously served for three years on the company's Board of Directors.”

Position

President

Company

Harmony Biosciences

Peter Anastasiou
Plymouth MeetingBiotechnologyHealth CareMedicalTherapeuticsBiopharma

Description

Peter Anastasiou has been appointed as president and Chief Executive Officer of Harmony Biosciences, effective January 1, 2027. He succeeds Jeffrey Dayno, who will retire at the end of 2026.

Other recent leadership changes in Medical and Therapeutics

Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.

Who to call at Harmony Biosciences, and when

A new leader at Harmony Biosciences brings new priorities and often new vendors. The first weeks are when they listen.

  • An alert the day Harmony Biosciences raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Harmony Biosciences, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Harmony Biosciences. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Harmony Biosciences

Location

630 W Germantown Pike

Plymouth Meeting, Pennsylvania, United States

About

At Harmony Biosciences, we specialize in developing and delivering treatments for rare neurological diseases that others often overlook. We believe that where empathy and innovation meet, a better life can begin for people living with neurological diseases. Established by Paragon Biosciences, LLC, in 2017 and headquartered in Plymouth Meeting, PA, our team of experts from a wide variety of disciplines and experiences is driven by our shared conviction that innovative science translates into therapeutic possibilities for our patients, who are at the heart of everything we do.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Harmony Biosciences changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

Ellen
Senior decision-maker at this company
••••••••@••••••••

See Ellen's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for Harmony Biosciences's next move

Learn about Strategic plan

Harmony Biosciences changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.